Pfizer beats and raises its earnings forecast (PFE)
REUTERS/Adam Hunger
- Pfizer reported adjusted earnings that topped Wall Street estimates thanks to strong sales of pneumonia vaccine Prevnar and arthritis drug Xeljanz.
- The drugmaker raised its adjusted earnings forecast, but lowered its revenue forecast.
(Reuters) - U.S. drugmaker Pfizer Inc posted a better-than-expected quarterly profit on Tuesday, driven by higher sales of pneumonia vaccine Prevnar and arthritis drug Xeljanz.
The company lowered its 2018 revenue expectation to between $53 billion and $55 billion, from $53.5 billion to $55.5 billion, due to a strengthening dollar.
See the rest of the story at Business Insider
NOW WATCH: Why Rolex watches are so expensive
See Also:
- Boeing says higher costs will weigh on defense margins
- Tesla is going to have major problems if it doesn’t get its cash burn under control
- Verizon beats, new subscribers top estimates
from Feedburner https://ift.tt/2vrgjfc
via IFTTT
Comments
Post a Comment